4//SEC Filing
Marquet Magda 4
Accession 0001493152-24-020781
CIK 0001873835other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:25 PM ET
Size
7.7 KB
Accession
0001493152-24-020781
Insider Transaction Report
Form 4
Marquet Magda
Director
Transactions
- Award
Common Stock
2024-05-15+25,002→ 25,002 total - Award
Common Stock
2024-05-20+21,155→ 46,092 total
Holdings
- 20,000(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024.
- [F2]Restricted Stock Awards which will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.
- [F3]Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity.
Documents
Issuer
Immix Biopharma, Inc.
CIK 0001873835
Entity typeother
Related Parties
1- filerCIK 0001631486
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:25 PM ET
- Size
- 7.7 KB